Determination of residues involved in ligand binding and signal transmission in the human IFN-α receptor 2

Journal of Immunology

Volumn 163, Issue 2, 1999, Pages 766-773

  Chuntharapai, A ^a   Gibbs, V ^b   Lu, J ^a   Ow, A ^b   Marsters, S ^a   Ashkenazi, A ^a   De Vos, A ^a   Kim, K Jin ^a  

^a GENENTECH INC   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR BINDING; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

EID: 0033565589     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Weissmann, C. 1986. The interferon genes. Prog. Nucleic Acid Res. Mol. Biol. 33:251.
2. Pestka, S., J. A. Langer, K. C. Zoon, and C. E. Samuel. 1987. Interferons and their actions. Annu. Rev. Biochem. 56:727.
3. Pestka, S. 1997. The interferon receptors. Semin. Oncol. 24, no. 3 Suppl 9:s9-18.
4. Domanski, P., and O. R. Colamonici. 1996. The type-I interferon receptor; the long and the short of it. Cytokine Growth Factor Rev. 7:143.
5. Uze, G., G. Lutfalla, and I. Gresser. 1990. Genetic transfer of a functional human interferon α receptor into mouse cells: cloning and expression of its cDNA. Cell 60:225.
6. Novick, D., B. Cohen, and M. Rubinstein. 1994. The human interferon α/β receptor: characterization and molecular cloning. Cell 77:391.
7. Domanski, P., M. Witte, M. Kellum, M. Rubinstein, R. Hackett, P. Pitha, and O. R. Colamonici. 1995. Cloning and expression of a long form of the β subunit of the interferon αβ receptor that is required for signaling. J. Biol. Chem. 270:21606.
8. Cohen, B., D. Novick, S. Barak, and M. Rubinstein. 1995. Ligand-induced association of the type I interferon receptor components. Mol. Cell. Biol. 15:4208.
9. Russell-Harde, D., H. Pu, M. Betts, R. N. Harkins, H. D. Perez, and E. Croze. 1995. Reconstitution of a high affinity binding site for type I interferons. J. Biol. Chem. 270:26033.
10. Cutrone, E. C., and J. A. Langer. 1997. Contributions of cloned type I interferon receptor subunits to differential ligand binding. FEBS Lett. 404:197.
11. Platanias, L. C., P. Domanski, O. W. Nadeau, T. Yi, S. Uddin, E. Fish, B. G. Neel, and O. R. Colamonici. 1998. Identification of a domain in the β subunit of the type I interferon (IFN) receptor that exhibits a negative regulatory effect in the growth inhibitory action of type I IFNs. J. Biol. Chem. 273:557.
12. Petricoin, E. F., S. Ito, B. L. Williams, S. Audet, L. F. Stancato, A. Camera, K. Clouse, P. Grimley, A. Weiss, J. Beeler, et al. 1997. Antiproliferative action of interferon-α requires components of T-cell-receptor signalling. Nature 390:629.
13. Darnell, J. E. 1994. STATs and gene regulation. Science 277:1630.
14. Haak-Frendscho. M., S. A. Marsters, J. Mordenti, S. Brady, N. A. Gillett, S. A. Chen, and A. Ashkenazi. 1994, Inhibition of TNF by a TNF receptor immunoadhesin: comparison to an anti-TNF monoclonal antibody. J. Immunol. 152:1347.
15. Rehberg, E., B. Kekter, E. G. Hoal, and S. Pestka. 1982. Specific molecular activities of recombinant and hybrid leukocyte interferons. J. Biol. Chem. 257:11497.
16. Horisberger, M. A., and S. Di Marco. 1995. Interferon-α hybrids. Pharmacol. Ther. 66:507.
17. Chuntharapai, A., and K. J. Kim. 1997. Generation of monoclonal antibodies to chemokine receptors. Methods Enzymol. 288:15.
18. Yelton, D. E., B. A. Diamond, S. P. Kwan, and M. D. Scharff. 1978, Fusion of mouse myeloma with spleen cells. Curr. Top. Microbiol. Immunol. 81:1.
19. Lu, J., A. Chuntharapai, J. Beck, S. Bass, A. Ow, A. M. De Vos, V. Gibbs, and K. J. Kim. 1998. Structure-function study of the extracellular domain of the human IFN-α receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2. J. Immunol. 160:1782.
20. Kim, K. J., M. Alphonso, C. H. Schmelzer, and D. Lowe. 1992. Detection of human leukemia inhibitory factor by monoclonal antibody based ELISA. J. Immunol. Methods 156:9.
21. Blake, D. A., P. Chakrabarti, M. Khosraviani, F. M. Hatcher, C. M. Westhoff, P. Goebel, D. E. Wylie, and R. C. Blake II. 1996. Metal binding properties of a monoclonal antibody directed toward metal-chelate complexes. J. Biol. Chem. 271:27677.
22. Craig, L., P. C. Sanschagrin, A. Rozek, S. Lackie, L. A. Kuhn, and J. K. Scott. 1998. The role of structure in antibody cross-reactivity between the peptides and folded proteins. J. Mol. Biol. 281:183.
23. Measurement of antiviral activity induced by interferons, α, β, and γ. 1992. In Current Protocols in Immunology, Vol. 1. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Wiley-Interscience, New York. Unit 6.9.1.
24. Kunkel, T. A., J. D. Roberts, and R. A. Zakour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367.
25. Cunningham, B. C., and J. A. Wells. 1991. Rational design of receptor-specific variants of human growth hormone. Proc Natl. Acad. Sci. USA 88:3407.
26. Bazan, J. F. 1990. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87:6934.
27. Bazan, J. F. 1990. Haemopoietic receptors and helical cytokines. Immunol. Today 11:350.
28. De Vos, A. M., M. Ultsch, and A. A. Kossiakoff. 1992. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306.
29. Muller, Y. A., M. H. Ultsch, and A. M. de Vos. 1996. The crystal structure of the extracellular domain of human tissue factor refined to 1.7 Å resolution. J. Mol. Biol. 256:144.
30. Seto, M. H., R. N. Harkins, M. Adler, M. Whitlow, W. B. Church, and E. Croze. 1995. Homology model of human interferon-α8 and its receptor complex. Protein Sci. 4:655.
31. Anonymous. 1989. Interferon-α and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. J. Neurol. Neurosurg. Psychiatry 52:566.
32. Bever, C. T. J., H. S. Panitch, H. B. Levy, D. E. McFarlin, and K. P. Johnson. 1990. Induction of γ interferon in patients with chronic progressive multiple sclerosis did not cause clinical deterioration. Neurology 40:259.
33. Platanias, L. C., S. Uddin, P. Domanski, and O. R. Colamonici. 1996. Differences in interferon α and β signaling: interferon β selectively induces the interaction of the α and βL subunits of the type I interferon receptor. J. Biol. Chem. 271:23630.
34. Rani, M. R. S., G. R. Foster, S. Leung, D. Leaman, G. R. Stark, and R. M. Ransohoff. 1996. Characterization of β-R1, a gene that is selectively induced by interferon β(IFN-β) compared with IFN-α. J. Biol. Chem. 271:22878.
35. Croze, E., D. Russell-Harde, T. C. Wagner, H. Pu, L. M. Pfeffer, and H. D. Perez. 1996. The human type I interferon receptor: identification of the interferon β-specific receptor-associated phosphoprotein. J. Biol. Chem. 271:33165.
36. Abramovich, D., L. M. Shulman, E. Ratovitski, S. Harroch, M. Tovey, P. Eid, and M. Revel. 1994. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-α and IFN-β. EMBO J. 13:5871.